Max Robotics — Global Service Robot Directory + US Certification

About

Babs M. Zonderhuis is a leading figure in minimally invasive hepato-pancreato-biliary (HPB) surgery, with a research focus on advancing surgical precision and safety through innovative techniques. Her major contributions center on the application of indocyanine green (ICG) fluorescence imaging to improve margin assessment during minimally invasive colorectal liver metastasis resections, a breakthrough that directly addresses the critical problem of unintended tumor-positive margins. In a landmark 2024 study (49 citations), she demonstrated how this real-time visualization can enhance oncologic outcomes. Zonderhuis also provides pivotal insights into the global shift from laparoscopic to robotic surgery, with a 2022 analysis of 600 procedures (39 citations) confirming the safety and feasibility of this transition. Her work extends to challenging malignancies, including a 2025 systematic review and meta-analysis on minimally invasive surgery for perihilar and intrahepatic cholangiocarcinoma, and a 2025 study on the impact of merging high-volume pancreatic surgery centers on patient outcomes. Through these contributions, Zonderhuis has established herself as a key voice in shaping the future of HPB surgery, driving evidence-based adoption of advanced technologies to improve patient care.